Astaxanthin Provides Antioxidant Protection in LPS-Induced Dendritic Cells for Inflammatory Control

Area of Science:

• Marine Biotechnology
• Immunology
• Oxidative Stress Research

Background:

• Astaxanthin is a marine-derived bioactive compound known for its potent antioxidant properties.
• Dendritic cells (DCs) are crucial immune regulators and a potential target for managing inflammatory conditions like sepsis.

Purpose of the Study:

• To investigate the antioxidant and anti-inflammatory effects of astaxanthin on dendritic cells.
• To evaluate astaxanthin's efficacy in an experimental sepsis model by examining its impact on oxidative stress and immune responses.

Main Methods:

• Assessed astaxanthin's impact on nitric oxide (NO), reactive oxygen species (ROS), and lipid peroxidation in lipopolysaccharide (LPS)-induced DCs and mice.
• Measured reduced glutathione (GSH) levels and the GSH/GSSG ratio to determine cellular reductive status.
• Quantified the activities of antioxidant enzymes (GPx, CAT, SOD) and inflammatory cytokines (IL-1β, IL-17, TGF-β).
• Investigated the role of the heme oxygenase 1 (HO-1)/nuclear factor erythroid 2-related factor 2 (Nrf2) pathway.

Main Results:

• Astaxanthin significantly suppressed NO, ROS production, and lipid peroxidation in LPS-induced DCs and mice.
• Elevated GSH levels and GSH/GSSG ratio indicated enhanced cellular reductive status.
• Upregulated activities of antioxidant enzymes (GPx, CAT, SOD) and inhibited pro-inflammatory cytokines (IL-1β, IL-17, TGF-β).
• Astaxanthin upregulated HO-1 and Nrf2 expression, highlighting the involvement of the HO-1/Nrf2 pathway.

Conclusions:

• Astaxanthin exhibits significant antioxidant and anti-inflammatory properties in dendritic cell-mediated inflammatory responses.
• The marine compound modulates oxidative stress via the HO-1/Nrf2 pathway.
• Astaxanthin shows potential as a therapeutic agent for sepsis treatment due to its immune-regulatory and antioxidant capabilities.